Beneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulators in postmenopausal women with type 2 diabetes and osteopenia/osteoporosis

MLA

Arina Miyoshi, et al. “Beneficial Effects of Switching to Denosumab from Bisphosphonates or Selective Estrogen Receptor Modulators in Postmenopausal Women with Type 2 Diabetes and Osteopenia/Osteoporosis.” Journal of Diabetes Investigation, vol. 12, no. 7, July 2021, pp. 1293–300. EBSCOhost, https://doi.org/10.1111/jdi.13458.

APA

Arina Miyoshi, Hiraku Kameda, So Nagai, Akinobu Nakamura, Aika Miya, Takahiro Takase, Tatsuya Atsumi, & Hideaki Miyoshi. (2021). Beneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulators in postmenopausal women with type 2 diabetes and osteopenia/osteoporosis. Journal of Diabetes Investigation, 12(7), 1293–1300. https://doi.org/10.1111/jdi.13458

Chicago

Arina Miyoshi, Hiraku Kameda, So Nagai, Akinobu Nakamura, Aika Miya, Takahiro Takase, Tatsuya Atsumi, and Hideaki Miyoshi. 2021. “Beneficial Effects of Switching to Denosumab from Bisphosphonates or Selective Estrogen Receptor Modulators in Postmenopausal Women with Type 2 Diabetes and Osteopenia/Osteoporosis.” Journal of Diabetes Investigation 12 (7): 1293–1300. doi:10.1111/jdi.13458.